juan lopez
@jd1lopez
El mundo de la Cardiologia, insuficiencia cardíaca crónica y trasplante de corazón. Cardiopatías Familiares.
ID: 2208157263
05-12-2013 01:28:21
21,21K Tweet
1,1K Followers
1,1K Following
Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis: The Lancet 🥸Plavix for secondary prevention may be superior to aspirin 😱 Summary 👇👇👇
🚀 PET/CT is rocking in cardiology guidelines! ✅ Superior to SPECT for CAD & CMD ✅ MBF/MBFR for risk stratification ✅ Stronger role in #Endocarditis, #Sarcoidosis, #Amyloidosis & transplant vasculopathy European Society of Cardiology American Heart Association journalofnuclearcardiology.org/article/S1071-… ASNC Society Journal of Nuclear Cardiology
A beautiful "explainer" of everything a cardiologist needs to know about #eGFR in HF clinical practice with modern #GDMT ...and a plug to bring back #eGFRslope as an endpoint in HF clinical trials New in #EHJ with leading nephrologists Brendon Neuen academic.oup.com/eurheartj/adva…
Los españoles que han abierto una nueva vía para tratar enfermedades del corazón genéticas | Vía El Confidencial elconfidencial.com/salud/2025-09-…
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy Among patients with nonobstructive HCM, mavacamten did not result in a significantly greater improvement in peak oxygen uptake or decrease in symptoms than placebo HF Collaboratory Improving Heart Function (iHF) NEJM